Cargando…

A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies

BACKGROUND: The patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is used to assess symptomatic adverse events in oncology trials. Currently, no standard for PRO-CTCAE analysis exists. METHODS: Key methods of descriptive analysis and longitudinal mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regnault, Antoine, Loubert, Angély, Gorsh, Boris, Davis, Randy, Cardellino, Anna, Creel, Kristin, Quéré, Stéphane, Sapra, Sandhya, Nelsen, Linda, Eliason, Laurie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165480/ https://www.ncbi.nlm.nih.gov/pubmed/36715639 http://dx.doi.org/10.1093/jnci/djad018

Ejemplares similares

Evaluating the impact of calibration of patient-reported outcomes measures on results from randomized clinical trials: a simulation study based on Rasch measurement theory
por: Loubert, Angély, et al.
Publicado: (2022)

Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis
por: Greene, Nupur, et al.
Publicado: (2023)

Is the St. George’s Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials
por: Loubert, Angely, et al.
Publicado: (2020)

Development of a keyword library for capturing PRO-CTCAE-focused “symptom talk” in oncology conversations
por: Durieux, Brigitte N, et al.
Publicado: (2023)

Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies
por: Regnault, Antoine, et al.
Publicado: (2023)

Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma
por: Popat, Rakesh, et al.
Publicado: (2023)

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE(®) to Provide Two Distinct and Complementary Perspectives
por: Minasian, Lori M, et al.
Publicado: (2022)

Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period
por: Lee, M. K., et al.
Publicado: (2023)

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)
por: Caminiti, Caterina, et al.
Publicado: (2022)

Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
por: Schroeder, Kristin M., et al.
Publicado: (2023)

Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure
por: Feldman, E., et al.
Publicado: (2023)

Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers
por: Günther, Maximilian, et al.
Publicado: (2023)

A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy
por: Christiansen, Mille Guldager, et al.
Publicado: (2023)

Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial
por: Lee, Mangyeong, et al.
Publicado: (2023)

The Microfluidic Toolbox for Analyzing Exosome Biomarkers of Aging
por: DeCastro, Jonalyn, et al.
Publicado: (2021)

The use of and adherence to CTCAE v3.0 in cancer clinical trial publications
por: Zhang, Sheng, et al.
Publicado: (2016)

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Wang, Tian Qi, et al.
Publicado: (2018)

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats
por: LeBlanc, Amy K., et al.
Publicado: (2021)

Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective cohort study
por: Bessou, Antoine, et al.
Publicado: (2022)

Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Miyaji, Tempei, et al.
Publicado: (2017)

Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
por: Veldhuijzen, Evalien, et al.
Publicado: (2020)

Score equivalence of paper-, tablet-, and interactive voice response system-based versions of PROMIS, PRO-CTCAE, and numerical rating scales among cancer patients
por: Lee, Minji K., et al.
Publicado: (2021)

Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
por: Mazza, Gina L., et al.
Publicado: (2021)

PRoNTo: Pattern Recognition for Neuroimaging Toolbox
por: Schrouff, J., et al.
Publicado: (2013)

P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY
por: Cohen, Jonathon, et al.
Publicado: (2023)

Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
por: KKF, Cheng, et al.
Publicado: (2020)

Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
por: Mazza, Gina L., et al.
Publicado: (2021)

PANDA: a pipeline toolbox for analyzing brain diffusion images
por: Cui, Zaixu, et al.
Publicado: (2013)

The Rametrix(™) PRO Toolbox v1.0 for MATLAB(®)
por: Senger, Ryan S., et al.
Publicado: (2020)

Qualitative study to characterize patient experience and relevance of patient-reported outcome measures for patients with metastatic synovial sarcoma
por: Eliason, Laurie, et al.
Publicado: (2022)

ProMod3—A versatile homology modelling toolbox
por: Studer, Gabriel, et al.
Publicado: (2021)

Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2021)

Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients
por: Baeksted, Christina, et al.
Publicado: (2017)

P1730: IMPLEMENTATION OF PRO-CTCAE QUESTIONNAIRE IN PROM PROGRAM COLLECTS DIFFERENT ADVERSE EVENTS PROFILE THAN PHYSICIANS AND REDUCE UNSCHEDULED HEALTHCARE IN PATIENTS WITH LYMPHOMA RECEIVING IV THERAPY
por: RAMOS, S., et al.
Publicado: (2022)

THU513 Are Endocrinologists Using CTCAE Grading System For Endocrine Side Effects Of Cancer Treatment With Immune Checkpoint Inhibitors?
por: Arnouk, Nelly, et al.
Publicado: (2023)

The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events
por: Kawaguchi, Takashi, et al.
Publicado: (2018)

Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data
por: ElAbd, Hesham, et al.
Publicado: (2021)

scHiCTools: A computational toolbox for analyzing single-cell Hi-C data
por: Li, Xinjun, et al.
Publicado: (2021)

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Bennett, Antonia V., et al.
Publicado: (2016)

A toolbox for a structured risk-based prehabilitation program in major surgical oncology
por: Sliwinski, Svenja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rkqpp0erp0eeaeif2jq0g0rldf